SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST (1490)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTE	COMPLEXITY
Anti-glomerular basement membrane (GBM) antibodies (K011348 | K011348)	HIGH Effective Date: 2001-06-22

Other General Immunology Devices:

Medical Device	Complexity
Beckman Coulter DxC 700 AU Clinical Chemistry Analyzer	View Complexity
Beckman Coulter AU5800 Chemistry analyzer	View Complexity
Siemens Dimension Vista 500	View Complexity
Behring Nephelometer 100	View Complexity
Abbott Architect c8000 System	View Complexity
Euroimmun Anti-Ribosomal P-proteins ELISA (IgG)	View Complexity
Beckman Coulter UniCel DxC 680i Synchron Access Clinical System	View Complexity
BIO-RAD LABORATORIES BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM	View Complexity
ALFA SCIENTIFIC DESIGNS INSTANT VIEW H. PYLORI WHOLE BLOOD RAPID TEST	View Complexity
RhiGene ANA ELISA TEST SYSTEM	View Complexity